GOLDMAN SACHS GROUP INC - IDERA PHARMACEUTICALS INC ownership

IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 56 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of IDERA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$41,000
+32.3%
39,326
+51.4%
0.00%
Q2 2021$31,000
-64.0%
25,976
+11.2%
0.00%
Q4 2020$86,000
+95.5%
23,360
+53.3%
0.00%
Q3 2019$44,000
+4.8%
15,242
-3.2%
0.00%
Q2 2019$42,000
-90.5%
15,748
-68.3%
0.00%
Q3 2018$442,00049,6590.00%
Other shareholders
IDERA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ABG Innovation Capital Partners III GP Ltd 56,250$68,0000.23%
Virtu Financial LLC 325,330$390,0000.04%
HOLLENCREST CAPITAL MANAGEMENT 141,000$169,0000.02%
Clear Creek Financial Management, LLC 49,696$60,0000.01%
Palo Alto Investors LP 77,044$92,0000.01%
ACADIAN ASSET MANAGEMENT LLC 738,620$886,0000.00%
MARSHALL WACE, LLP 477,449$573,0000.00%
WADE G W & INC 35,000$42,0000.00%
TWO SIGMA ADVISERS, LP 599,471$719,0000.00%
BRYN MAWR TRUST Co 33,892$41,0000.00%
View complete list of IDERA PHARMACEUTICALS INC shareholders